[HTML][HTML] Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics

M Ekinci, TM Magne, LMR Alencar, PBA Fechine… - Pharmaceutics, 2024 - mdpi.com
It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …

Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics.

M Ekinci, TM Magne, LMR Alencar… - …, 2024 - search.ebscohost.com
It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …

Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics.

M Ekinci, TM Magne, LMR Alencar, PBA Fechine… - …, 2024 - europepmc.org
It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …

[HTML][HTML] Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics

M Ekinci, TM Magne, LMR Alencar, PBA Fechine… - …, 2024 - ncbi.nlm.nih.gov
It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …

Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics

M Ekinci, TM Magne, LMR Alencar… - …, 2024 - pubmed.ncbi.nlm.nih.gov
It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …

Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics.

M Ekinci, TM Magne, LMR Alencar, PBA Fechine… - …, 2024 - europepmc.org
It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …